2011 - Fellow of the American Psychological Association (APA)
Lisa A. Marsch focuses on Psychiatry, Psychological intervention, Buprenorphine, Addiction and Abstinence. The Methadone, Methadone maintenance and Low income and middle income countries research she does as part of her general Psychiatry study is frequently linked to other disciplines of science, such as Narrative review, therefore creating a link between diverse domains of science. Her Psychological intervention study incorporates themes from Mental health, Mental illness and Substance abuse.
Her Substance abuse research incorporates themes from Clinical study design, Cognitive skill, Meta-analysis and Clinical psychology. Her work deals with themes such as Psychotherapist, Epidemiology and Chronic pain, which intersect with Addiction. Her Abstinence research includes themes of Intervention, Internal medicine and Standard treatment.
Her scientific interests lie mostly in Psychological intervention, Psychiatry, Intervention, Buprenorphine and Randomized controlled trial. Her Psychological intervention research is multidisciplinary, incorporating perspectives in Health care, Emergency department, Substance abuse, Behavior change and Addiction. Her Psychiatry study integrates concerns from other disciplines, such as Young adult and Clinical psychology.
The various areas that Lisa A. Marsch examines in her Intervention study include Health education, Family medicine and Medical emergency. Her studies in Buprenorphine integrate themes in fields like Opioid use disorder and Naltrexone. She has included themes like Web application, Physical therapy and Confidence interval in her Randomized controlled trial study.
Her primary areas of investigation include Opioid use disorder, Health care, Mental health, Digital health and Family medicine. Her research investigates the connection with Opioid use disorder and areas like Buprenorphine which intersect with concerns in Naltrexone. Lisa A. Marsch interconnects Nursing, Public health and Clinical trial in the investigation of issues within Health care.
The Randomized controlled trial study combines topics in areas such as Pain catastrophizing, Psychiatry and Substance dependence. Her Psychiatry study combines topics from a wide range of disciplines, such as Intention to use and Trial registration. Her Psychological intervention research incorporates themes from Addiction medicine, Addiction, Internet privacy and Healthcare delivery.
Lisa A. Marsch mainly focuses on Health care, Suicide prevention, Family medicine, Opioid use disorder and Digital health. Her biological study spans a wide range of topics, including Psychiatry, Substance abuse, Clinical trial and Public health. Lisa A. Marsch incorporates Family medicine and Buprenorphine in her research.
Her research integrates issues of mHealth, Data-driven and Data science in her study of Digital health. Her research in Heroin intersects with topics in Expanded access, Medical prescription and Abstinence. Her Telemedicine research incorporates elements of Psychological intervention, Social media, Test and McNemar's test.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toward a behavioral economic understanding of drug dependence: delay discounting processes
Warren K. Bickel;Lisa A. Marsch.
The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta‐analysis
Lisa A. Marsch.
Opioids and the treatment of chronic pain: controversies, current status, and future directions.
Andrew Rosenblum;Lisa A. Marsch;Herman Joseph;Russell K. Portenoy.
Experimental and Clinical Psychopharmacology (2008)
The future of mental health care: peer-to-peer support and social media
J. A. Naslund;K. A. Aschbrenner;L. A. Marsch;S. J. Bartels.
Epidemiology and Psychiatric Sciences (2016)
Deconstructing relative reinforcing efficacy and situating the measures of pharmacological reinforcement with behavioral economics: a theoretical proposal.
Warren K. Bickel;Lisa A. Marsch;Marilyn E. Carroll.
Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money.
Louis A. Giordano;Warren K. Bickel;George Loewenstein;Eric A. Jacobs.
Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature
John A Naslund;John A Naslund;Kelly A Aschbrenner;Ricardo Araya;Lisa A Marsch.
The Lancet Psychiatry (2017)
Emerging mHealth and eHealth interventions for serious mental illness: a review of the literature
John A. Naslund;Lisa A. Marsch;Gregory J. McHugo;Stephen J. Bartels.
Journal of Mental Health (2015)
Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Lisa A. Marsch;Warren K. Bickel;Gary J. Badger;Marne E. Stothart.
Archives of General Psychiatry (2005)
Computerized Behavior Therapy for Opioid-Dependent Outpatients: A Randomized Controlled Trial
Warren K. Bickel;Lisa A. Marsch;August R. Buchhalter;Gary J. Badger.
Experimental and Clinical Psychopharmacology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: